News

Article

April 11, 2025

Daily Derm Times: April 11, 2025

Author(s):

Menopausal acne treatment should consider hormonal shifts, skin sensitivity, and emotional well-being for effective management.
Codex Labs' lotion is the first eczema OTC topical certified as microbiome-friendly and accepted by the NEA.
Subcutaneous methotrexate may improve efficacy and adherence in psoriasis treatment compared to oral forms, despite higher costs.
Ruxolitinib cream, approved for vitiligo and atopic dermatitis, may have potential off-label applications for other inflammatory skin diseases.
Shea butter-based emollients are effective for treating pediatric erythema, and acupuncture reduces frown lines with lasting satisfaction.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Menopausal acne is rising yet underexplored; treatment must address hormonal shifts, skin sensitivity, and patient emotional well-being.

The company also announced in a press release that the product received the Seal of Acceptance by the NEA.

Subcutaneous methotrexate may offer improved efficacy and patient adherence in psoriasis treatment, though it comes at a higher cost.

While approved for vitiligo and atopic dermatitis, ruxolitinib cream may help treat other inflammatory skin diseases.

The presentation, led by Amy Paller, MS, MD, highlighted the upcoming phase 3 SELVA study for microcystic lymphatic malformations.

Satisfaction levels remained high at 12 weeks post-treatment among those who received acupuncture.

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.